Literature DB >> 1550170

Preterm premature rupture of membranes: results of expectant management in patients with cervical cultures positive for group B streptococcus or Neisseria gonorrhoeae.

G L Maxwell1, W J Watson.   

Abstract

OBJECTIVE: The antepartum course and short-term neonatal outcome for patients with premature rupture of membranes between 26 and 33 weeks' gestation with positive cervical cultures for group B streptococcus or Neisseria gonorrhoeae were reviewed. STUDY
DESIGN: A retrospective analysis of 182 patients managed expectantly over a 3-year period was done. Thirty-four patients had cervical cultures positive for group B streptococcus, 11 had positive cultures for Neisseria gonorrhoeae, and 137 had negative cultures. Prophylactic antibiotics were routinely given, and antibiotic therapy was continued in patients with positive cultures.
RESULTS: There was no difference between groups in latent phase or maternal morbidity. The incidence of neonatal pneumonia was increased in those with positive cervical cultures (p = 0.009, odds ratio 6.9, 90% confidence interval 2.1 to 22.8), but there was no difference in neonatal sepsis, respiratory distress, or neonatal mortality.
CONCLUSION: These data support the conservative or expectant management of premature rupture of membranes between 26 and 33 weeks in patients with positive cervical cultures who are given prophylactic antibiotic therapy.

Entities:  

Mesh:

Year:  1992        PMID: 1550170     DOI: 10.1016/0002-9378(92)91369-l

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  7 in total

Review 1.  Epidemiology of gonorrhoea: a global perspective.

Authors:  Robert D Kirkcaldy; Emily Weston; Aluisio C Segurado; Gwenda Hughes
Journal:  Sex Health       Date:  2019-09       Impact factor: 2.706

2.  Is antenatal group B streptococcal carriage a predictor of adverse obstetric outcome?

Authors:  S M Garland; N Kelly; A M Ugoni
Journal:  Infect Dis Obstet Gynecol       Date:  2000

3.  Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines.

Authors:  Emilie Alirol; Teodora E Wi; Manju Bala; Maria Luiza Bazzo; Xiang-Sheng Chen; Carolyn Deal; Jo-Anne R Dillon; Ranmini Kularatne; Jutta Heim; Rob Hooft van Huijsduijnen; Edward W Hook; Monica M Lahra; David A Lewis; Francis Ndowa; William M Shafer; Liz Tayler; Kimberly Workowski; Magnus Unemo; Manica Balasegaram
Journal:  PLoS Med       Date:  2017-07-26       Impact factor: 11.069

4.  Current status of Neisseria gonorrhoeae cervicitis in pregnant women in Japan.

Authors:  Shunji Suzuki; Shin-Ichi Hoshi; Akihiko Sekizawa; Yoko Sagara; Masanobu Tanaka; Katsuyuki Kinoshita; Tadaichi Kitamura
Journal:  PLoS One       Date:  2019-02-07       Impact factor: 3.240

5.  Adverse pregnancy and neonatal outcomes associated with Neisseria gonorrhoeae: systematic review and meta-analysis.

Authors:  Lisa M Vallely; Dianne Egli-Gany; Handan Wand; William S Pomat; Caroline S E Homer; Rebecca Guy; Bronwyn Silver; Alice R Rumbold; John M Kaldor; Andrew J Vallely; Nicola Low
Journal:  Sex Transm Infect       Date:  2021-01-12       Impact factor: 3.519

6.  Antimicrobial resistance of Neisseria gonorrhoeae isolated from patients attending sexually transmitted infection clinics in Urban Hospitals, Lusaka, Zambia.

Authors:  Kelvin L Sarenje; Owen Ngalamika; Margaret C Maimbolwa; Amon Siame; Sody M Munsaka; Geoffrey Kwenda
Journal:  BMC Infect Dis       Date:  2022-08-12       Impact factor: 3.667

7.  Utility of Routine Testing for Chlamydia and Gonorrhea in the Setting of Preterm Delivery or Premature Preterm Rupture of Membranes.

Authors:  Kaitlynn Ebisutani; Charlie K Wang; Hyeong Jun Ahn; Autumn J Broady; Bliss Kaneshiro
Journal:  Hawaii J Health Soc Welf       Date:  2021-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.